Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,030,356
+$135,951 QoQ
Shares Held
4,057
+10.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#2,998
of 4,676 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FORTEM FINANCIAL GROUP, LLC holds $5,722,803 across 5 Drug Manufacturers - General names. JNJ ranks #3 (18.0% of the industry book) .
All Filings in JNJ
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,030,356 | 4,057 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $894,405 | 3,659 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $610,709 | 2,951 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $582,960 | 3,144 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $487,730 | 3,193 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $263,685 | 1,590 | Shares | Sole | 2025-05-01 | |
| 2022-12-31 | $248,016 | 1,404 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $232,461 | 1,423 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $340,641 | 1,919 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,865,877 | 10,528 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,916,497 | 11,203 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,772,139 | 10,973 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,791,053 | 10,872 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,680,643 | 10,226 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,870,618 | 11,886 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $2,600,635 | 17,468 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $706,665 | 5,025 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $706,528 | 5,388 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||